Table: Delta-Fly Pharma - 6-MTH parent results

Delta-Fly Pharma

14/11/2022 06:05

Nov 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Sep 30, 2022        Sep 30, 2021       Mar 31, 2023  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales                                100 mln           300 mln     
                (-100.0 pct)         (+0.0 pct)         (+0.0 pct)   
  Operating     loss 611 mln        loss 554 mln        loss 1.15    
  Recurring     loss 620 mln        loss 555 mln        loss 1.15    
  Net           loss 622 mln        loss 557 mln        loss 1.15    
  EPS          loss 114.88 yen     loss 102.97 yen   loss 212.20 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T